Drug intelligence / Profile preview

BCMA panCAR

Development stage
Preclinical
Lead developer
Orna Therapeutics
Modality
CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intravenous
01

Overview

BCMA panCAR is an investigational chimeric antigen receptor (CAR) cell therapy being developed by **Xianbo Biotechnology** (also known as **Simnova Bio**) in collaboration with **Orna Therapeutics**. The therapy utilizes Xianbo's proprietary **panCAR** platform, which is designed to enhance the precision and efficacy of CAR-based treatments. By targeting the **B-cell maturation antigen (BCMA)**, a protein highly expressed on the surface of malignant plasma cells, the therapy aims to treat hematologic malignancies such as multiple myeloma. The partnership with Orna Therapeutics likely leverages Orna's circular RNA (oRNA) technology, which may be used to facilitate the expression of the CAR construct, potentially through *in vivo* delivery or optimized *ex vivo* engineering.

Other names
BCMA-targeted panCARBCMA panCAR cell therapy
02

Targets

BCMA (B-cell maturation antigen)

Beyond the preview

Go deeper on BCMA panCAR.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCMA panCAR.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call